Quest Diagnostics Q4 revenue $2.62B (+14.5%), adjusted EPS $2.23 (+3.7%); raises dividend 6.7% to $0.80

QUEST DIAGNOSTICS INC

2024-FY EPS reported $7.69 revenue$9,872,000,000

Q4 revenue $2.62B (+14.5% YoY); reported diluted EPS $1.95 (+14.7%); adjusted diluted EPS $2.23 (+3.7%).
Full year 2024 revenue $9.87B (+6.7%); reported EPS $7.69 (+2.7%); adjusted EPS $8.93 (+2.5%).
FY2025 guidance: revenue $10.70-10.85B; reported EPS $8.34-8.59; adjusted EPS $9.55-9.80; cash ops ~$1.45B.
Quarterly dividend raised 6.7% to $0.80 ($3.20 annual), payable Apr 21, 2025 to holders of record Apr 7, 2025.
Completed 8 acquisitions in 2024 (including LifeLabs); extended health plan access to >90% of in-network lives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.